In this work, we also showed that angiogenin and its two recently identified receptors, EGFR and PLXNB2,45,58 were upregulated at the protein level by ccRCC cancer cells as compared to their cell type of origin ex vivo. This evidence concerns the gene EGFR and nonpapillary renal cell carcinoma.